Sanchez-Garcia, Joaquin <br/><br/>
Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia.  [electronic resource] 

 -  Leukemia & lymphoma  05 2018 
 - 1095-1104 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2017.1366998  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anemia--epidemiology<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Azacitidine--therapeutic use<br/>Blood Transfusion--methods<br/>Chromosome Deletion<br/>Chromosomes, Human, Pair 5--genetics<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--genetics<br/>Palliative Care<br/>Prognosis<br/>Prospective Studies<br/>Survival Rate